Within GI tumors, DCLK1 is strongly correlated with an EMT phenotype and tumor immune suppressive infiltrates including tumor-associated macrophages, M2 macrophages, and T regulatory cells. This evidence concerns the gene DCLK1 and digestive system neoplasm.